financetom
Business
financetom
/
Business
/
Helix Energy Secures Deal With Denmark's NKT as T3600 Subsea Trencher Service Provider
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Helix Energy Secures Deal With Denmark's NKT as T3600 Subsea Trencher Service Provider
Jul 17, 2025 6:29 AM

09:14 AM EDT, 07/17/2025 (MT Newswires) -- Helix Energy Solutions Group ( HLX ) said Thursday it has been chosen as a service provider for Danish power cables manufacturer NKT's T3600 Subsea Trencher under a four-year agreement.

The agreement includes installation, offshore operations, engineering and maintenance of the T3600 subsea trencher, which will be deployed on a Helix-provided support vessel, Helix Energy said.

The agreement includes an initial commitment of 800 days of vessel operations over four years, commencing in 2027, with options for extension, the company said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
PSQ Holdings Launches New Payment Platform, Announces 35% Staff Reduction
PSQ Holdings Launches New Payment Platform, Announces 35% Staff Reduction
Nov 3, 2024
07:23 AM EDT, 10/28/2024 (MT Newswires) -- PSQ Holdings ( PSQH ) said Monday it launched its payments platform and received a $5.4 million public equity investment while simultaneously announcing a plan to reduce its staff by 35%. Chief Executive Michael Seifert said the community is aiming for annualized payment processing of $1 billion by Christmastime. We have also recognized...
Eli Lilly's Mirikizumab Shows Long-Term Remission in Phase 3 Inflammatory Bowel Diseases Studies
Eli Lilly's Mirikizumab Shows Long-Term Remission in Phase 3 Inflammatory Bowel Diseases Studies
Nov 3, 2024
07:28 AM EDT, 10/28/2024 (MT Newswires) -- Eli Lilly ( LLY ) said Monday that phase 3 studies of its drug mirikizumab showed sustained stable, long-term remission in patients across two inflammatory bowel diseases, ulcerative colitis and Crohn's disease. One study showed that mirikizumab helped 81% of patients with moderately to severely active ulcerative colitis to maintain long-term clinical remission,...
PROCEPT BioRobotics Q3 Loss Narrows, Revenue Increases; Shares Up Pre-Bell
PROCEPT BioRobotics Q3 Loss Narrows, Revenue Increases; Shares Up Pre-Bell
Nov 3, 2024
07:28 AM EDT, 10/28/2024 (MT Newswires) -- PROCEPT BioRobotics ( PRCT ) reported a Q3 net loss Monday of $0.40 per diluted share, compared with a loss of $0.51 a year earlier. Analysts surveyed by Capital IQ expected a loss of $0.49. Revenue for the quarter ended Sept. 30 was $58.4 million, up from $35.1 million a year earlier. Analysts...
Dutch Health Tech Firm Philips' Q3 Earnings Miss Expectations, Lowers Annual Forecasts On Weak Demand In China
Dutch Health Tech Firm Philips' Q3 Earnings Miss Expectations, Lowers Annual Forecasts On Weak Demand In China
Nov 3, 2024
On Monday, Koninklijke Philips NV ( PHG ) reported third-quarter adjusted EPS of 0.32 euros (or $0.35), missing the consensus of 0.35 euros. “In the quarter, demand from hospitals and consumers in China further deteriorated, while we continue to see solid growth in other regions. We have adjusted our full-year sales outlook to reflect the continued impact from China,” said...
Copyright 2023-2026 - www.financetom.com All Rights Reserved